{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:22:31Z","timestamp":1771935751722,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate and compare the efficacy and safety of clopidogrel and aspirin, as well as their combination, in patients with chronic coronary syndrome (CCS), and to provide evidence-based support for long-term antiplatelet therapy in stable coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted in CNKI, WanFang, PubMed, Web of Science, and Embase databases from January 1990 to July 2025. Randomized controlled trials comparing clopidogrel and aspirin as monotherapy or in combination in patients with CCS were included. Relative risk (RR) or mean difference (MD) with 95% confidence intervals (CI) were pooled using fixed- or random-effects models according to heterogeneity. Publication bias and sensitivity analyses were performed where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 24 studies involving patients with chronic coronary syndrome were included. Compared with aspirin monotherapy, clopidogrel monotherapy was associated with a numerically lower incidence of myocardial infarction, although the difference was not statistically significant. No significant difference in the risk of serious bleeding events was observed between clopidogrel and aspirin. Combination therapy with clopidogrel and aspirin was associated with a higher treatment response rate and a tendency toward reduced angina frequency compared with aspirin alone; however, substantial heterogeneity was present, and the observed benefits were mainly confined to subjective or semi-quantitative outcomes. The incidence of common adverse reactions, including gastrointestinal discomfort, dizziness, and headache, was numerically lower in the combination therapy group, but these differences did not reach statistical significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with chronic coronary syndrome, clopidogrel represents a reasonable alternative to aspirin for long-term antiplatelet therapy, with comparable efficacy and safety. Combination therapy with clopidogrel and aspirin may offer modest improvements in symptom-related outcomes; however, these findings should be interpreted cautiously due to heterogeneity, potential publication bias, and the subjective nature of some endpoints. Individualized antiplatelet strategies based on ischemic and bleeding risk remain essential in stable coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251108327<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1723015","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:33:50Z","timestamp":1771310030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of clopidogrel and aspirin in patients with chronic coronary syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinzheng","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Gongshu District People\u2019s Hospital of Intergrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Gongshu District People\u2019s Hospital of Intergrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Gongshu District People\u2019s Hospital of Intergrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Gongshu District People\u2019s Hospital of Intergrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengwei","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Gongshu District People\u2019s Hospital of Intergrated Traditional Chinese and Western Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8295054","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","article-title":"Mortality from ischemic heart disease: analysis of data from the world health organization and coronary artery disease risk factors from NCD risk factor collaboration","volume":"12","author":"Nowbar","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B3","first-page":"e213","volume-title":"The Cost of Coronary Heart Disease and the Promise of Prevention","author":"Almarzooq","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.amjmed.2011.04.010","article-title":"The impact of the aging population on coronary heart disease in the United States","volume":"124","author":"Odden","year":"2011","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1079\/PHN2001298","article-title":"Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action","volume":"5","author":"Reddy","year":"2002","journal-title":"Public Health Nutr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet agents for the treatment and prevention of coronary atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48s","DOI":"10.18433\/jpps29854","article-title":"Clinical outcomes of aspirin interaction with other non-steroidal anti-inflammatory drugs: a systematic review","volume":"21","author":"Alqahtani","year":"2018","journal-title":"J Pharm Pharm Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/bjs.4810","article-title":"Randomized clinical trial of the antiplatelet effects of aspirin\u2013clopidogrel combination versus aspirin alone after lower limb angioplasty","volume":"92","author":"Cassar","year":"2005","journal-title":"J Br Surg"},{"key":"B10","volume-title":"Dual Antiplatelet Therapy Versus Aspirin in Patients with Stroke or Transient Ischemic Attack: Meta-analysis of Randomized Controlled Trials","author":"Bhatia","year":"2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e000576","DOI":"10.1161\/SVIN.122.000576","article-title":"Antiplatelet resistance: a review of concepts, mechanisms, and implications for management in acute ischemic stroke and transient ischemic attack","volume":"3","author":"Krishnan","year":"2023","journal-title":"Stroke Vasc Interv Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cpcardiol.2017.01.006","article-title":"Upper gastrointestinal toxicity associated with long-term aspirin therapy: consequences and prevention","volume":"42","author":"Lavie","year":"2017","journal-title":"Curr Probl Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0143-4160(03)00170-2","article-title":"Inhibition of ADP-induced intracellular Ca2+responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1","volume":"35","author":"Fox","year":"2004","journal-title":"Cell Calcium"},{"key":"B14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.12669\/pjms.35.2.87","article-title":"Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention","volume":"35","author":"Zhang","year":"2019","journal-title":"Pak J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"H488","DOI":"10.1152\/ajpheart.1994.267.2.H488","article-title":"Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis","volume":"267","author":"Yao","year":"1994","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/00003495-200767040-00013","article-title":"Clopidogrel: a review of its use in the prevention of thrombosis","volume":"67","author":"Plosker","year":"2007","journal-title":"Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e31642","DOI":"10.1371\/journal.pone.0031642","article-title":"Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.2146\/ajhp060662","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin","volume":"65","author":"Sullivan","year":"2008","journal-title":"Am J Health-Syst Pharm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/TCRM.S80437","article-title":"Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy","volume":"11","author":"Wang","year":"2025","journal-title":"Ther Clin Risk Manag"},{"key":"B20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000442706","article-title":"Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR study)","volume":"134","author":"Lemesle","year":"2016","journal-title":"Cardiology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e002816","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents","volume":"9","author":"Park","year":"2016","journal-title":"Circ: Cardiovasc Interventions"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/j.1538-7836.2004.01017.x","article-title":"A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial","volume":"2","author":"Woodward","year":"2004","journal-title":"J Thromb Haemostasis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3978\/j.issn.2072-1439.2014.02.23","article-title":"Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation","volume":"6","author":"Zhuang","year":"2014","journal-title":"J Thorac Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1253\/circj.CJ-20-0298","article-title":"Clopidogrel monotherapy vs. Aspirin monotherapy following short-term dual antiplatelet therapy in patients receiving everolimus-eluting coronary stent implantation","volume":"84","author":"Natsuaki","year":"2020","journal-title":"Circ J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3969\/j.issn.1006-1959.2025.14.025","article-title":"Clinical efficacy of clopidogrel sulfate and aspirin in the treatment of coronary heart disease","volume":"38","author":"Qian","year":"2025","journal-title":"Med Inf"},{"key":"B28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14163\/j.cnki.11-5547\/r.2025.10.026","article-title":"Observation of the effect of enteric-coated aspirin combined with clopidogrel in the treatment of coronary heart disease angina","volume":"20","author":"Han","year":"2025","journal-title":"Chin Pract Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.20256\/j.cnki.zgdxbl.20250513.002","article-title":"Efficacy and safety analysis of clopidogrel combined with enteric-coated aspirin in the treatment of coronary heart disease angina","volume":"19","author":"Qiying","year":"2025","journal-title":"China Typical Case Collection"},{"key":"B30","first-page":"49","article-title":"Application effect of aspirin combined with clopidogrel in elderly stable coronary heart disease patients","volume":"4","author":"Fen","year":"2025","journal-title":"Chin Foreign Med Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.20256\/j.cnki.zgdxbl.20250418.001","article-title":"Observation of the therapeutic effect of enteric-coated aspirin combined with clopidogrel in coronary heart disease angina","volume":"19","author":"Weirui","year":"2025","journal-title":"China Typical Case Collection"},{"key":"B32","first-page":"31","article-title":"Application effect of aspirin combined with clopidogrel in stable coronary heart disease patients after percutaneous coronary intervention","volume":"4","author":"Jinmei","year":"2025","journal-title":"Chin Foreign Med Res"},{"key":"B33","first-page":"75","article-title":"Clinical effect and safety analysis of clopidogrel combined with aspirin in elderly coronary heart disease","volume":"4","author":"Xiaolan","year":"2025","journal-title":"Chin Foreign Med Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3969\/j.issn.1007-614x.2024.35.008","article-title":"Application effect of clopidogrel combined with aspirin in community elderly coronary heart disease patients","volume":"40","author":"Yisha","year":"2024","journal-title":"China Commun Physician"},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3969\/j.issn.1007-614x.2024.31.011","article-title":"Observation of the therapeutic effect of clopidogrel combined with aspirin in elderly coronary heart disease","volume":"40","author":"Juan","year":"2024","journal-title":"China Commun Physician"},{"key":"B36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3969\/j.issn.1006-1959.2024.17.025","article-title":"Efficacy and safety analysis of clopidogrel combined with enteric-coated aspirin in the treatment of coronary heart disease angina","volume":"37","author":"Guoliang","year":"2024","journal-title":"Med Inf"},{"key":"B37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3969\/j.issn.1674-9316.2024.16.028","article-title":"Clinical effect of aspirin combined with clopidogrel in elderly coronary heart disease","volume":"15","author":"Jingguo","year":"2024","journal-title":"China Health Stand Manag"},{"key":"B38","first-page":"24","article-title":"Clinical effect analysis of clopidogrel combined with aspirin in elderly coronary heart disease","volume":"3","author":"Li","year":"2024","journal-title":"Chinese Foreign Med Res"},{"key":"B39","first-page":"24","article-title":"Clinical effect analysis of clopidogrel combined with aspirin in elderly coronary heart disease","volume":"3","author":"Xiaohong","year":"2024","journal-title":"Chin Foreign Med Res"},{"key":"B40","first-page":"365","article-title":"Therapeutic effect and safety observation of aspirin and clopidogrel in elderly coronary heart disease","volume":"53","author":"Yuan","year":"2024","journal-title":"Heilongjiang Trad Chin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.14164\/j.cnki.cn11-5581\/r.2024.06.027","article-title":"Clinical efficacy analysis of clopidogrel combined with aspirin in elderly coronary heart disease","volume":"18","author":"Zhongwei","year":"2024","journal-title":"Chinese Modern Drug Appl"},{"key":"B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14163\/j.cnki.11-5547\/r.2024.02.024","article-title":"Therapeutic effect and safety observation of aspirin and clopidogrel in elderly coronary heart disease","volume":"19","author":"Guozhen","year":"2024","journal-title":"Chinese Pract Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1055\/a-1853-2952","article-title":"Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis","volume":"122","author":"Tasoudis","year":"2022","journal-title":"Thromb Haemostasis"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2025.04.042","volume-title":"Antiplatelet Monotherapy After Short DAPT in ACS: Aspirin, Clopidogrel, and the Art of Clinical Judgment","author":"Greco","year":"2025"},{"key":"B46","doi-asserted-by":"publisher","first-page":"004045","DOI":"10.12890\/2023_004045","article-title":"Thrombocytopenia induced by clopidogrel: a rare adverse effect","volume":"10","author":"T\u00e1vora","year":"2023","journal-title":"Eur J Case Rep Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1537776","DOI":"10.3389\/fphar.2025.1537776","article-title":"A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance","volume":"16","author":"Hou","year":"2025","journal-title":"Front Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"13","author":"Byrne","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/13543776.2025.2467683","article-title":"P2y12r antagonists in antithrombotic therapy: a patent and literature review (2019\u2013present)","volume":"35","author":"Chen","year":"2025","journal-title":"Expert Opin Ther Pat"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1723015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:29:24Z","timestamp":1771932564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1723015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":50,"alternative-id":["10.3389\/fcvm.2026.1723015"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1723015","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1723015"}}